Account verification for pain management and physical medicine practices
A Port St. Lucie pain management or physical medicine practice opens a Precision Biologics account by submitting its NPI number and delivery address, then completing a short verification step before pricing and ordering access are enabled. This structure keeps ordering authority with licensed professionals, consistent with how interstate biologics distribution is generally handled.
Given the smaller number of pain medicine and physical medicine specialists registered in Port St. Lucie itself, some practices in this specialty serve a broader surrounding area; account verification and documentation requirements are the same regardless of practice size.
Port St. Lucie
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
3- Pain Medicine
- 0
- Physical Medicine & Rehabilitation
- 3
Cold-chain and shelf-stable shipping to Southeast Florida
Cryopreserved Wharton's jelly and exosome formats ship overnight on dry ice in validated containers and require freezer capacity on arrival; lyophilized formats are shelf-stable and do not need cryogenic storage, which can simplify receiving for a smaller practice.
Each shipment carries a unique lot identifier, which a practice logs against the certificate of analysis and sterility testing record for that lot at the patient-record level.
Setting up an account and getting documentation
A practice can request a documentation packet covering registration and licensure status, certificate-of-analysis samples, and donor eligibility summaries, and schedule a peer-to-peer call focused on specifications and paperwork rather than clinical use.
Once internal sign-off is complete, most practices move from documentation review directly to a first order.
Regulatory verification in Florida
We recommend a Port St. Lucie practice confirm its own use decisions with its medical director and verify current requirements with the Florida Board of Medicine and its own counsel. Florida's SB 1768, effective July 1, 2025, allows certain MD/DO physicians to use non-FDA-approved stem cell therapies in pain management, among other specialties, with informed consent, but it does not change the federal FDA status of any specific product.
FDA has also stated there are no FDA-approved exosome products; purchase and clinical use decisions for exosome products remain with the physician and the practice's regulatory counsel.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Is there a minimum practice size to open an account in Port St. Lucie?+
No. Any licensed clinic or physician that completes NPI verification can open an account, regardless of practice size.
Does SB 1768 apply to exosome products as well as Wharton's jelly products?+
SB 1768 addresses physician use of certain non-FDA-approved stem cell therapies under Florida law. It does not change the fact that FDA has stated there are no FDA-approved exosome products, and it does not override federal regulation of any product.
What happens if a cold-chain shipment arrives before staff can receive it?+
We recommend confirming delivery windows and designating a specific receiving contact before the first shipment ships, so a cryopreserved product reaches the freezer promptly.